Trial Profile
Clinical Trial of Umbilical Cord-Derived Mesenchymal Stem Cells Transplantation for Rheumatoid Arthritis-Phase I/II
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy-Alliancells Bioscience (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Alliancells-PuRui Bioscience
- 14 Apr 2015 New trial record